Philippe Bedard Received 2025 TAT Honorary Award for Contributions to Cancer Research
The European Society for Medical Oncology (ESMO) recently announced that Philippe Bedard has received the 2025 TAT Honorary Award.
Philippe Bedard is a Medical Oncologist and Professor of Medicine at the University of Toronto, with over 15 years of experience in the field of oncology.
He has been a part of the University Health Network in Toronto, Canada, since 2010, working at the Princess Margaret Cancer Centre, one of the world’s leading cancer treatment facilities.
Dr. Bedard specializes in breast cancer, focusing on clinical trials and developing advanced treatment strategies. His work aims to improve care and outcomes for breast cancer patients, and he has contributed significantly to research in this area.
Over the years, he has become known for his expertise in oncology, particularly in breast cancer therapies.
Dr. Bedard earned his MD from the University of Toronto in 2003, followed by specialized training in Internal Medicine and Medical Oncology, completing his FRCPC between 2003 and 2008. Prior to his current role, he worked as a Clinical Research Fellow with the Breast International Group from 2008 to 2009.
Dr. Bedard underwent further fellowship training in clinical and translational research at the Breast International Group (BIG). In 2012, the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) honored him with a Career Development Award.
He will deliver his award lecture ‘Bridging cancer genomics and drug development: An academic perspective’ on 3 March 2025, at the ESMOTAT25 in Paris.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023